Aclaris Therapeutics Deal History & Licensing Activity
Aclaris Therapeutics is a large biotech headquartered in US. The company currently has 3 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
2
Active Trials
3
Top Modality
N/A
Focus Area
Solid Tumors
Aclaris Therapeutics Pipeline Focus
Therapeutic areas and modalities where Aclaris Therapeutics is most active based on deal history and clinical trial data.
Therapeutic Areas
Aclaris Therapeutics Clinical Pipeline
Aclaris Therapeutics has 3 active clinical trials across 2 development phases.
2
Phase 1
1
Phase 2
See How Your Asset Matches Aclaris Therapeutics's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
About Aclaris Therapeutics Licensing & Deal Activity
Aclaris Therapeutics is a large biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape.
Key therapeutic areas of focus for Aclaris Therapeutics include Solid Tumors (2 deals and trials), and Autoimmune (1 deal and trial).
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Aclaris Therapeutics and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Aclaris Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.